What is ADVANCED OXYGEN TECHS INC's earnings per share (EPS)?

ADVANCED OXYGEN TECHS INC (AOXY) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

ADVANCED OXYGEN TECHS INC (AOXY) Financials

AOXY

Trailing 12 months to March 31, 2026

Revenue $44K -2.6% YoY

Net Income $3K -46.9% YoY

EPS (Diluted) $0.00 YoY not available

Operating Cash Flow $50K +24.8% YoY

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported May 12, 2026 Currency USD FYE June

Newest figures come from the 10-Q for Q3 FY2026, filed May 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AOXY SEC filings page.

ADVANCED OXYGEN TECHS INC (AOXY) reported $44K in revenue over the twelve months to Mar 31, 2026, down 2.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AOXY FY2025 2026-08-29

Cash conversion is the dominant mechanic: a small, steady-revenue business generates cash while carrying persistent short-term funding pressure.

Operating cash flow was roughly 10x net income in FY2025, after being about 8x earnings in FY2024. That recurring gap means reported profit understates the cash produced by the business, with non-cash or working-capital movements playing a larger role than the income statement alone suggests.

The balance sheet became less dependent on long-term borrowing: debt-to-equity fell to 0.0x and long-term debt reached $0 in FY2025, while equity rose from $342K to $416K. Yet current assets of $58K remained well below current liabilities of $150K, leaving liquidity tighter than solvency.

Revenue stayed near $40K across FY2023–FY2025, while operating margin moved from 28.4% to 31.7%. The margin recovery without a major sales expansion points more toward changing cost absorption or business mix than a scale-driven growth story.

Financial Health Signals

Financial health score not available

ADVANCED OXYGEN TECHS INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-41.41

ADVANCED OXYGEN TECHS INC scores -41.41, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($250K) relative to total liabilities ($277K). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/8

ADVANCED OXYGEN TECHS INC passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

9.77x

For every $1 of reported earnings, ADVANCED OXYGEN TECHS INC generates $9.77 in operating cash flow ($40K OCF vs $4K net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$12K

YoY+13.5%

QoQ+2.4%

5Y CAGR+2.9%

10Y CAGR+2.8%

ADVANCED OXYGEN TECHS INC generated $12K in revenue in Q3 2026. This represents an increase of 13.5% from the same quarter a year earlier. Against the prior quarter it is up 2.4%.

Net Income

$3K

YoY+22.5%

QoQ+30.4%

5Y CAGR+20.2%

10Y CAGR+10.2%

ADVANCED OXYGEN TECHS INC reported $3K in net income in Q3 2026. This represents an increase of 22.5% from the same quarter a year earlier. Against the prior quarter it is up 30.4%.

EPS (Diluted)

$0.00

ADVANCED OXYGEN TECHS INC earned $0.00 per diluted share (EPS) in Q3 2026.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Cash & Debt

$35K

YoY-40.0%

QoQ+2.0%

5Y CAGR-5.3%

10Y CAGR-2.8%

ADVANCED OXYGEN TECHS INC held $35K in cash against $0 in long-term debt as of Q3 2026, with $256K of liabilities due within a year.

Shares Outstanding

YoY0.0%

QoQ0.0%

5Y CAGR0.0%

10Y CAGR+3.7%

ADVANCED OXYGEN TECHS INC had 3M shares outstanding in Q3 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Operating Margin

50.4%

YoY+2.2pp

QoQ+6.3pp

ADVANCED OXYGEN TECHS INC's operating margin was 50.4% in Q3 2026, reflecting core business profitability. This is up 2.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.3 percentage points.

Net Margin

28.7%

YoY+2.1pp

QoQ+6.2pp

5Y change+15.5pp

10Y change+14.4pp

ADVANCED OXYGEN TECHS INC's net profit margin was 28.7% in Q3 2026, showing the share of revenue converted to profit. This is up 2.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.2 percentage points.

Return on Equity

0.9%

YoY+0.1pp

QoQ+0.2pp

5Y change+0.5pp

10Y change-0.1pp

ADVANCED OXYGEN TECHS INC's ROE was 0.9% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Gross Margin

Not reported for Q3 2026.

Capital Allocation

None of these metrics is reported for Q3 2026.

AOXY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AOXY quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$44K	$43K+2.0%	$43K+8.0%	$39K-0.3%	$40K-4.6%	$41K-4.0%	$43K+12.4%	$38K-3.4%	$40K+10.7%	$36K-0.9%	$36K-6.1%	$39K-13.9%	$45K-27.9%	$62K+19.7%	$52K+23.9%	$42K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$873	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$44K-29.3%	$62K+19.7%	$52K+23.9%	$42K
SG&A Expenses	$6K	$7K+0.5%	$7K-5.4%	$7K-4.6%	$7K-15.2%	$9K+31.8%	$7K+80.6%	$4K+4.4%	$3K-35.3%	$5K+19.5%	$5K+7.3%	$4K-25.8%	$6K-54.6%	$12K+30.6%	$10K+211.2%	$3K
Operating Income	$13K	$14K-4.7%	$14K+29.0%	$11K	N/A	$17K+118.1%	-$92K-579.9%	$19K	N/A	N/A	N/A	N/A	N/A	$35K-19.7%	$43K+155.5%	-$78K
Interest Expense	N/A	N/A	$296-61.6%	$771-60.3%	$2K-27.7%	$3K-18.4%	$3K-21.3%	$4K-28.0%	$6K-12.8%	$7K-19.5%	$8K-20.5%	$10K-58.4%	$25K+475.4%	$4K-8.0%	$5K-20.7%	$6K
Income Tax	$10K	$10K+8.7%	$9K+12.5%	$8K+1.4%	$8K-2.4%	$8K+5.6%	$8K+13.4%	$7K-4.4%	$7K-15.9%	$9K+86.6%	$5K+188.8%	-$5K-106.1%	$85K	N/A	N/A	N/A
Net Income	$3K	$4K-25.6%	$6K+145.0%	$2K-96.0%	$57K+891.9%	$6K+105.6%	-$103K-1371.2%	$8K+8.8%	$7K+82744.4%	$9-99.9%	$11K-39.3%	$18K+128.0%	-$65K-291.8%	$34K+272.4%	-$20K-128.4%	$69K
EPS (Basic)	N/A	$0.00	$0.00	$0.00-100.0%	$0.02	$0.00+100.0%	-$0.03-1233.3%	$0.00	$0.00	$0.00-100.0%	$0.00-39.2%	$0.01	N/A	$0.00+275.0%	$0.00-126.7%	$0.00
EPS (Diluted)	$0.00	$0.00	$0.00	$0.00-100.0%	$0.02	$0.00+100.0%	-$0.03-1233.3%	$0.00	$0.00	$0.00-100.0%	$0.00+160.8%	-$0.01	N/A	$0.00+275.0%	$0.00-126.7%	$0.00
Diluted Shares (Avg)	N/A	3M0.0%	3M0.0%	3M0.0%	3M0.0%	3M+7.8%	3M+33.0%	2M0.0%	2M0.0%	2M	N/A	21M	N/A	N/A	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$12K+13.5%	$12K-11.6%	$12K+8.2%	$9K-18.3%	$11K-1.7%	$13K+26.2%	$11K+2.4%	$11K+0.7%
SG&A Expenses	$1K-1.8%	$2K+35.6%	$1K-36.6%	$2K-3.2%	$1K+7.5%	$2K-9.2%	$2K+7.1%	$2K+366.0%
Operating Income	$6K+18.7%	$5K-33.2%	-$973+55.2%	$3K-38.0%	$5K-5.3%	$8K+60.2%	-$2K-182.0%	$5K-9.7%
Interest Expense	N/A	N/A	N/A	N/A	N/A	$352-3.0%	$0-100.0%	-$145-240.8%
Income Tax	$3K+14.1%	$3K-14.3%	$2K+7.4%	$2K+7.7%	$2K-20.5%	$3K+66.0%	$2K+1.9%	$2K+0.6%
Net Income	$3K+22.5%	$3K-48.6%	-$3K+23.0%	$643-76.3%	$3K+11.8%	$5K+50.0%	-$4K-44.1%	$3K-13.1%
EPS (Basic)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
EPS (Diluted)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Diluted Shares (Avg)	3M0.0%	3M0.0%	3M0.0%	N/A	3M0.0%	3M0.0%	3M0.0%	N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, EBITDA.

AOXY Balance Sheet

AOXY quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$693K+2.6%	$675K-3.2%	$698K+5.4%	$662K-5.0%	$697K+6.6%	$654K-0.8%	$660K-4.1%	$688K+2.5%	$671K+4.4%	$643K-4.8%	$675K-4.7%	$708K+21.2%	$584K+4.5%	$559K-14.6%	$655K
Current Assets	$58K-38.8%	$96K-9.8%	$106K+11.2%	$95K+86.0%	$51K+14.4%	$45K+1.1%	$44K-19.7%	$55K+7.1%	$52K+8.9%	$47K-31.8%	$69K-32.2%	$102K+1674.4%	$6K+2589.2%	-$232-100.7%	$32K
Cash & Equivalents	$57K-39.4%	$94K-9.9%	$105K+11.3%	$94K+88.5%	$50K+14.6%	$44K+1.2%	$43K-19.3%	$53K+6.1%	$50K+9.0%	$46K-32.4%	$68K-32.3%	$101K+1645.9%	$6K	$0-100.0%	$24K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$277K-16.7%	$333K-3.9%	$347K+1.3%	$343K-2.5%	$351K+1.0%	$348K-2.9%	$359K-5.7%	$380K-0.2%	$381K+0.7%	$378K-8.6%	$414K-17.3%	$500K+60.6%	$312K-2.6%	$320K-28.4%	$447K
Current Liabilities	$150K-27.1%	$206K-6.2%	$220K+5.5%	$209K+5.8%	$197K-35.1%	$304K+2.5%	$296K-0.2%	$297K-22.1%	$381K+48.9%	$256K-3.2%	$264K+14.8%	$230K+5.8%	$218K-3.5%	$226K-21.5%	$287K
Non-Current Liabilities	$127K0.0%	$127K0.0%	$127K-5.2%	$134K-13.1%	$154K+247.2%	$44K-28.9%	$62K-25.1%	$83K-15.5%	$99K-19.5%	$123K-18.1%	$150K-44.6%	$270K+187.5%	$94K-0.6%	$95K-40.8%	$160K
Long-Term Debt	$0-100.0%	$127K-5.2%	$134K-11.2%	$151K-13.0%	$173K-8.0%	$189K	N/A	N/A	N/A	$273K	N/A	N/A	N/A	N/A	N/A
Total Equity	$416K+21.5%	$342K-2.5%	$351K+9.7%	$320K-7.6%	$346K+13.1%	$306K+1.7%	$301K-2.2%	$308K+6.0%	$290K+9.8%	$264K+1.3%	$261K-0.1%	$261K-4.3%	$273K+14.2%	$239K-7.6%	$259K
Retained Earnings	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M+0.3%	-$20.8M0.0%	-$20.8M-0.5%	-$20.7M0.0%	-$20.7M0.0%	-$20.7M0.0%	-$20.7M+0.1%	-$20.8M+0.1%	-$20.8M-0.3%	-$20.7M+0.2%	-$20.7M-0.1%	-$20.7M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$655K+1.6%	$670K+6.5%	$681K-1.8%	$693K+2.6%	$645K-6.7%	$629K-11.2%	$694K+2.9%	$675K-3.2%
Current Assets	$36K-39.1%	$35K-46.4%	$47K-47.6%	$58K-38.8%	$59K-44.7%	$66K-39.8%	$89K-13.0%	$96K-9.8%
Cash & Equivalents	$35K-40.0%	$34K-47.4%	$46K-48.2%	$57K-39.4%	$58K-45.2%	$65K-40.2%	$88K-13.2%	$94K-9.9%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$256K-12.1%	$254K-17.2%	$268K-17.6%	$277K-16.7%	$291K-15.7%	$307K-11.8%	$326K-6.9%	$333K-3.9%
Current Liabilities	$256K-12.1%	$254K-17.2%	$268K-17.6%	$150K-27.1%	$291K-15.7%	$307K-11.8%	$326K-6.9%	$206K-6.2%
Non-Current Liabilities	$0	$0	$0	$127K0.0%	$0	$0	$0	$127K0.0%
Long-Term Debt	$0	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%	$127K0.0%	$127K-1.8%	$127K-5.2%
Total Equity	$399K+12.9%	$416K+29.2%	$413K+12.1%	$416K+21.5%	$353K+2.4%	$322K-10.7%	$368K+13.5%	$342K-2.5%
Retained Earnings	-$20.7M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.

AOXY Cash Flow Statement

AOXY quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$50K	$40K-10.4%	$45K+27.5%	$35K-60.5%	$90K+137.6%	$38K+3.8%	$36K+108.7%	$17K-50.2%	$35K+24.8%	$28K+338.5%	-$12K-599.4%	$2K+102.9%	-$81K-1338.5%	$7K-87.5%	$53K-46.0%	$97K
Stock-Based Compensation	N/A	N/A	N/A	N/A	N/A	N/A	$113K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	-$125	N/A	N/A	N/A	N/A	N/A	N/A	-$19K-130.6%	$63K+164.8%	-$98K
Financing Cash Flow	-$84K	-$90K-69.5%	-$53K-81.7%	-$29K+12.4%	-$33K+0.7%	-$34K+5.3%	-$35K-34.6%	-$26K+20.1%	-$33K-27.3%	-$26K-235.8%	-$8K+87.2%	-$60K-134.1%	$176K+22776.8%	-$777	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$11K+17.3%	$15K+101.2%	$10K+9.2%	$14K+0.5%	$10K+6.4%	$7K-44.7%	$10K+5.7%	$14K+9.4%
Financing Cash Flow	-$10K+49.3%	-$26K-4.9%	-$22K-11.2%	-$26K-10.5%	-$19K-105.1%	-$25K-119.8%	-$20K-122.2%	-$23K-240.4%

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.

AOXY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AOXY quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	98.0%-1.9pp	100.0%0.0pp	100.0%0.0pp	100.0%
Operating Margin	31.7%-2.2pp	33.9%+5.5pp	28.4%	N/A	40.3%	-213.2%	49.9%	N/A	N/A	N/A	N/A	N/A	55.7%-27.3pp	83.0%	-185.5%
Net Margin	9.5%-3.6pp	13.1%+7.3pp	5.8%	144.2%	13.9%	-238.9%	21.1%+2.4pp	18.8%+18.7pp	0.0%-30.4pp	30.4%-16.7pp	47.1%	-144.8%	54.4%+92.2pp	-37.8%	165.1%
Return on Equity	1.0%-0.6pp	1.6%+1.0pp	0.7%-17.2pp	17.8%+16.2pp	1.7%+35.4pp	-33.7%-36.4pp	2.7%+0.3pp	2.4%+2.4pp	0.0%-4.2pp	4.2%-2.8pp	7.0%+31.8pp	-24.9%-37.3pp	12.4%+20.6pp	-8.2%-35.0pp	26.8%
Return on Assets	0.6%-0.2pp	0.8%+0.5pp	0.3%-8.3pp	8.6%+7.8pp	0.8%+16.6pp	-15.8%-17.0pp	1.2%+0.1pp	1.1%+1.1pp	0.0%-1.7pp	1.7%-1.0pp	2.7%+11.8pp	-9.2%-14.9pp	5.8%+9.3pp	-3.5%-14.1pp	10.6%
Current Ratio	0.39-0.1x	0.460.0x	0.480.0x	0.46+0.2x	0.26+0.1x	0.150.0x	0.150.0x	0.19+0.1x	0.140.0x	0.19-0.1x	0.26-0.2x	0.44+0.4x	0.030.0x	0.00-0.1x	0.11
Debt-to-Equity	0.00-0.4x	0.370.0x	0.38-0.1x	0.470.0x	0.50-0.1x	0.62-0.6x	1.190.0x	1.24-0.1x	1.31+0.3x	1.03-0.6x	1.59-0.3x	1.92+0.8x	1.14-0.2x	1.34-0.4x	1.73
Asset Turnover	0.060.0x	0.060.0x	0.060.0x	0.060.0x	0.060.0x	0.070.0x	0.060.0x	0.060.0x	0.050.0x	0.060.0x	0.060.0x	0.060.0x	0.110.0x	0.090.0x	0.06

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Margin	50.4%+2.2pp	44.1%-14.3pp	-8.3%+11.7pp	35.5%-11.3pp	48.2%-1.9pp	58.4%+12.4pp	-20.0%-12.7pp	46.8%-5.3pp
Net Margin	28.7%+2.1pp	22.6%-16.3pp	-29.2%+11.9pp	7.4%-18.1pp	26.6%+3.2pp	38.9%+6.2pp	-41.1%-11.9pp	25.4%-4.0pp
Return on Equity	0.9%+0.1pp	0.6%-1.0pp	-0.8%+0.4pp	0.1%-0.6pp	0.8%+0.1pp	1.6%+0.7pp	-1.2%-0.3pp	0.8%-0.1pp
Return on Assets	0.5%+0.1pp	0.4%-0.4pp	-0.5%+0.1pp	0.1%-0.3pp	0.4%+0.1pp	0.8%+0.3pp	-0.6%-0.2pp	0.4%0.0pp
Current Ratio	0.14-0.1x	0.14-0.1x	0.17-0.1x	0.39-0.1x	0.20-0.1x	0.21-0.1x	0.270.0x	0.460.0x
Debt-to-Equity	0.000.0x	0.00-0.4x	0.00-0.3x	0.00-0.4x	0.00-0.4x	0.390.0x	0.34-0.1x	0.370.0x
Asset Turnover	0.020.0x	0.020.0x	0.020.0x	0.010.0x	0.020.0x	0.020.0x	0.020.0x	0.020.0x

Not reported in any period shown, so not listed: Gross Margin, FCF Margin.

Note: The current ratio is below 1.0 (0.39), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Where ADVANCED OXYGEN TECHS INC Ranks

Frequently Asked Questions

What is ADVANCED OXYGEN TECHS INC's annual revenue?

ADVANCED OXYGEN TECHS INC (AOXY) reported $43K in total revenue for fiscal year 2025. This represents a 2.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is ADVANCED OXYGEN TECHS INC's revenue growing?

ADVANCED OXYGEN TECHS INC (AOXY) revenue grew by 2.0% year-over-year, from $43K to $43K in fiscal year 2025.

Is ADVANCED OXYGEN TECHS INC profitable?

Yes, ADVANCED OXYGEN TECHS INC (AOXY) reported a net income of $4K in fiscal year 2025, with a net profit margin of 9.5%.

How much debt does ADVANCED OXYGEN TECHS INC have?

As of fiscal year 2025, ADVANCED OXYGEN TECHS INC (AOXY) had $57K in cash and equivalents against $0 in long-term debt.

What is ADVANCED OXYGEN TECHS INC's operating margin?

ADVANCED OXYGEN TECHS INC (AOXY) had an operating margin of 31.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is ADVANCED OXYGEN TECHS INC's net profit margin?

ADVANCED OXYGEN TECHS INC (AOXY) had a net profit margin of 9.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is ADVANCED OXYGEN TECHS INC's return on equity (ROE)?

ADVANCED OXYGEN TECHS INC (AOXY) has a return on equity of 1.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is ADVANCED OXYGEN TECHS INC's operating cash flow?

ADVANCED OXYGEN TECHS INC (AOXY) generated $40K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are ADVANCED OXYGEN TECHS INC's total assets?

ADVANCED OXYGEN TECHS INC (AOXY) had $693K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does ADVANCED OXYGEN TECHS INC have outstanding?

ADVANCED OXYGEN TECHS INC (AOXY) had 3M shares outstanding as of fiscal year 2025.

What is ADVANCED OXYGEN TECHS INC's current ratio?

ADVANCED OXYGEN TECHS INC (AOXY) had a current ratio of 0.39 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is ADVANCED OXYGEN TECHS INC's debt-to-equity ratio?

ADVANCED OXYGEN TECHS INC (AOXY) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is ADVANCED OXYGEN TECHS INC's return on assets (ROA)?

ADVANCED OXYGEN TECHS INC (AOXY) had a return on assets of 0.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is ADVANCED OXYGEN TECHS INC's Altman Z-Score?

ADVANCED OXYGEN TECHS INC (AOXY) has an Altman Z-Score of -41.41, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is ADVANCED OXYGEN TECHS INC's Piotroski F-Score?

ADVANCED OXYGEN TECHS INC (AOXY) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are ADVANCED OXYGEN TECHS INC's earnings high quality?

ADVANCED OXYGEN TECHS INC (AOXY) has an earnings quality ratio of 9.77x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.